Cargando…

2347. Impact of Multidisciplinary Review of Clostridioides difficile Testing

BACKGROUND: Minimizing Clostridioides difficile infections (CDI) is an important patient safety goal due to significant cost and disease burden with CDI causing 15,000 deaths annually in the United States. Diagnosis of CDI is complicated when DNA amplification assay will return positive for both col...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foreman, Jena, Belter, Neha, Thannum, Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809626/ http://dx.doi.org/10.1093/ofid/ofz360.2025

Ejemplares similares

2347. Factors Associated with COVID-19 and Influenza Vaccine Coadministration in Rhode Island
por: Gargano, Lisa M, et al.
Publicado: (2023)

2339. Clostridioides difficile: Impact of Active Screening of Asymptomatic Carriers and Testing Stewardship
por: Beth Graham, Mary, et al.
Publicado: (2019)

71. Diagnostic Stewardship of Clostridioides difficile Testing
por: Qamar, Zahra, et al.
Publicado: (2021)

672. Impact of Multistep Testing Algorithm on Hospital Acquired Clostridioides difficile Infection Rates
por: Betancourth, Adriana C, et al.
Publicado: (2023)

Amplificateur de tete MPS 2347
por: Barbalat, O, et al.
Publicado: (1967)

2347. Antiviral Use Is Associated With a Decrease in Rate of Influenza-Related Complications and Resource Utilization
por: Wallick, Christopher, et al.
Publicado: (2018)

129. Evaluation of Two-Step Clostridioides difficile Testing on Treatment Exposure
por: Bennett, Nicholas, et al.
Publicado: (2023)

104. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Bettger, Caitlin C, et al.
Publicado: (2020)

755. Clostridioides difficile Testing and the Use of Laxatives in Immunocompromised Adults
por: Al-Bahou, Amanda, et al.
Publicado: (2021)

2399. Ribotype Diversity of Clostridioides difficile strains obtained during screening tests
por: Munoz-Price, L Silvia, et al.
Publicado: (2019)

2361. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Zuccaro, Patricia, et al.
Publicado: (2019)

1710. Clostridioides difficile Bundle Implementation Reduces Unnecessary Testing in Pediatric Patients
por: Sietsema, Lydia, et al.
Publicado: (2023)

157. Implementation of multidisciplinary diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital
por: Sasaki, Yasuhiro, et al.
Publicado: (2023)

1982. A Diagnostic Stewardship Intervention for Clostridioides difficile: Impact of Stool Toxin Testing on Treatment of Adult Inpatients
por: Moss, Jason, et al.
Publicado: (2019)

2413. Assessment of compliance with Clostridioides difficile prophylaxis guideline and its efficacy on secondary prophylaxis and reducing hospital-onset Clostridioides difficile infections.
por: Vyas, Nikunj M, et al.
Publicado: (2019)

1203. Impact of Antimicrobial Stewardship Interventions on Hospital-Onset Clostridioides difficile Infections
por: Kwon, Taesung, et al.
Publicado: (2023)

Persistent Burkholderia pseudomallei Bacteremia in A Filipino Immigrant to the United States: A Case Report
por: Meraj, Sumbul, et al.
Publicado: (2019)

1663. Clostridioides difficile testing following 18706 Pediatric Procedures: Implications for Diagnostic Stewardship
por: Negi, Ruchita, et al.
Publicado: (2023)

2387. Learning the Influence of Individual Clostridioides difficile Infections
por: Mu, Emily, et al.
Publicado: (2019)

471. Prevalence and Characteristics of Clostridioides difficile Infection in Bangladesh
por: Sofjan, Amelia K, et al.
Publicado: (2018)

400. Rehospitalization of Patients for Recurrent Clostridioides difficile Infection
por: Drwiega, Emily, et al.
Publicado: (2022)

135. Impact of Clostridioides difficile Toxin Confirmation on Subsequent C. difficile Treatment in a Rural Health System (IT-CDI)
por: Crawford, Jacquelyn, et al.
Publicado: (2023)

2435. The Impact of Treatment Strategy and Toxin Status on Outcomes of Patients with Clostridioides difficile Infections
por: Friedman, Daniel, et al.
Publicado: (2019)

2364. Surprising Prescribing: Treatment Practices following Addition of Toxin Testing to an Existing Molecular Test for Clostridioides difficile
por: Miller, Ryan, et al.
Publicado: (2019)

2404. Molecular Epidemiology of Clostridioides difficile in the United States, 2017
por: Paulick, Ashley, et al.
Publicado: (2019)

2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients
por: Olvera, Adilene, et al.
Publicado: (2019)

529. Overdiagnosis of Clostridioides difficile with a Multiplex PCR Panel
por: Arora, Vaneet, et al.
Publicado: (2018)

381. Antibiotic Spectrum Index and Risk of Clostridioides difficile Infection
por: Ray, Michael J, et al.
Publicado: (2022)

P18 Audit on compliance with the preventive measures on Clostridioides difficile
por: Marques Reis, I, et al.
Publicado: (2023)

707. Molecular Epidemiology of Clostridioides difficile Colonization in Families with Infants
por: Toltzis, Philip, et al.
Publicado: (2023)

2373. Impact of a Change in Testing Strategy for Clostridioides difficile Infection on a Publicly Reported Metric and Treatment Days of Therapy
por: Miller, Ryan, et al.
Publicado: (2019)

2351. Rate and Consequences of Missed Clostridioides (Clostridium) difficile Infection Diagnosis from Non-disclosure of Clostridioides difficile Multiplex PCR Results. Two-Hospital Experience
por: Zacharioudakis, Ioannis, et al.
Publicado: (2019)

751. Impact of Changing from a Three-step to Two-step Testing Algorithm for the Diagnosis of Clostridioides difficile
por: Lapin, Jonathan, et al.
Publicado: (2021)

694. Impact of COVID-19 Pandemic on Clostridioides difficile Infection Rates and Risk Factors in Maryland
por: Marceaux-Galli, Kaytlynn, et al.
Publicado: (2023)

677. To Treat or Not To Treat: Patients with Clostridioides difficile PCR-positive/Toxin EIA negative Test Results
por: Yang, Krista, et al.
Publicado: (2023)

2430. Comorbidity and Severity of Illness Risk Adjustment for Hospital-Onset Clostridioides difficile Infection
por: Cabral, Stephanie, et al.
Publicado: (2019)

2409. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems
por: Perry, Donald A, et al.
Publicado: (2019)

2397. Effects of antimicrobial surgical prophylaxis on rates of Clostridioides difficile infection
por: Hayes, Sarah K, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

661. In vitro Activity of Omadacycline and Comparator Antibiotics against Clostridioides difficile
por: Skinner, Andrew M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fjmkhd3h2qgq4ja8omhf81g7r8